Nancy Dvorin

Managing Editor

20 Years of Experience


@NancyDvorin has been covering and analyzing the medical device and pharmaceutical industries for more than 20 years. Prior to joining MedTech Strategist, she was the managing editor of several life sciences business publications including In Vivo and Medtech Insight. Earlier in her career, Nancy managed library and information services for a number of multinational corporations.

Articles from Nancy Dvorin:

Perspective & Commentary

Digital Edition: Market Pathways April 2022, Vol. 4 No. 4

The MDUFA V user fee reauthorization agreement is now in the hands of Congress. We highlight three recent Market Pathways stories tracking initial reactions from US lawmakers. Also inside: the European Medical Device Regulation has been in effect for a year, but trade associations in Germany and France argue that timelines need to be pushed back to avoid a regulatory and market crisis. And CDRH's Kevin Fu advocates a total product lifecycle approach to combat medtech cybersecurity risks.

Read Article